Dominique Sirena

As VP Operations and Technology of GlycoEra, Dominique is responsible for overseeing all operations of the company and aligning the company’s operations with its goals and strategy. In addition, he leads the research, CMC process and analytical development to establish cGMP and industry compliant manufacturing processes and analytical methods.

Dominique was a co-founder and COO of LimmaTech Biologics AG and was responsible for process and analytical development of LimmaTech’s vaccine candidates prior to his focusing on GlycoEra. He joined GlycoVaxyn AG in 2011 as Head of Process Development and Industrialization and held that position at the time of the company’s acquisition by GlaxoSmithKline plc in February 2015. Before this, he acquired significant experience in cGMP quality control, manufacturing and validation while working for more than 5 years at Cytos Biotechnology AG. Dominique holds a PhD in science from the University of Zurich and studied Adenovirus biology and its application in tumor therapy.